Lepu Medical Technology (Beijing) Co., Ltd. was established in 1999. It is specialized in developing, manufacturing and marketing the high-tech medical devices and equipment. Today, Lepu Medical has grown into a global leading group company in the fields of cardiovascular interventions, structural heart diseases, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery with products include coronary stents, dilatation balloon catheters, interventional accessories, occlusion devices, mechanical heart valves, electrophysiology catheters, pacemakers, in vitro diagnostic equipment and biomarkers, DSA systems and surgical staplers. In 2009, Lepu Medical successfully went public, and listed on ChiNext Shenzhen Stock Exchange Market (stock code: 300003).


To build Lepu Medical into a large-scale global company in the cardiovascular industry that provides products and solutions covering prevention, treatment and rehabilitation for the patients with cardiovascular and related diseases.
To develop Lepu Medical into one of the largest supplier of cardiovascular related products and services on the platforms of medical device, medicine, healthcare products, healthcare service and new medical mode.
To set up a comprehensive online and offline service platform for cardiovascular health, and provide Chinese people with omnipresent care all the while.


To establish the China's leading industry chain for cardiovascular health with the 4 in 1 platform including medical devices, pharmaceutical, healthcare service and new medical mode.